This concentration-dependent shift between pro-proliferative and anti-proliferative effects is modulated by tumor development stage and the degree of hypoxia within the microenvironment: in early-stage tumors, where oxygen partial pressure is approximately 1–5%, eNOS predominantly produces low levels of NO, supporting proliferation. Here, NOS3 is linked to neoplasm.